SHAHER ALTOUMAH: Open Payments
NPI 1962976712 · LOMA LINDA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,101 in 31 payments from 11 companies in 2025. Trend: 2023 $86 · 2024 $761 · 2025 $1,101
Food & beverage: $1,101
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $280 |
| Amgen Inc. | 9 | $219 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $186 |
| Exact Sciences Corporation | 5 | $147 |
| GENZYME CORPORATION | 1 | $105 |
| Novo Nordisk Inc | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Lilly USA, LLC | 1 | $26 |
| Edwards Lifesciences Corporation | 1 | $23 |
| SHIELD THERAPEUTICS INC | 1 | $16 |
Products named: AIRSUPRA, Kerendia, REPATHA, The Cologuard Plus Collection Kit, DUPIXENT, OTEZLA, LEQVIO, FARXIGA.
Industry payments across CA — which companies pay providers there.
